Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Cord Blood Stem Cells

Unrelated umbilical cord blood transplantation in children with immune deficiency: results of a multicenter study

Abstract

In the absence of a related donor, unrelated cord blood transplant (CBT) may be a potential option for patients with a primary immune deficiency (PID). Most published experience consists of single-center data using multiple preparative regimens and GVHD prophylaxis. We report the results of a multicenter prospective trial of unrelated CBT for PID. A total of 24 children with PID, with a median age of 1 year (range: 0.23–7.81 years) and a median weight of 10.5 kg (range: 4–24.4 kg) received unrelated CBT between 1999 and 2003. All patients received a fully ablative conditioning regimen with identical GVHD prophylaxis and supportive care. Most patients (79%) received a 1 or 2 HLA Ag-mismatched cord unit with a median nucleated cell infused of 9.3 × 107/kg (range: 1.0–31.2) and a median CD34 of 2.7 × 105/kg 2.9 (range: 0.6–84.5). The cumulative incidence of neutrophil engraftment by day 42 was 58% (95% CI: 38–79%) at a median of 19 days. Cumulative incidence estimates of grade III–IV acute GVHD at day 100 and chronic GVHD at 1 year were 29% (95% CI: 10–48%) and 24% (95% CI: 3–44%), respectively. The probability of survival at 180 days and 1 year was 66.7% (95% CI: 44.3–81.7%) and 62.5% (95% CI: 40.3–78.4%), respectively. Unrelated CBT should be considered in children with PID.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Antoine C, Muller S, Cant A, Cavazzana-Calvo M, Veys P, Vossen J et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99. Lancet 2003; 361: 553–560.

    Article  PubMed  Google Scholar 

  2. Diaz de Heredia C, Ortega JJ, Diaz MA, Olive T, Badell I, Gonzalez-Vicent M et al. Unrelated cord blood transplantation for severe combined immunodeficiency and other primary immunodeficiencies. Bone Marrow Transplant 2008; 41: 627–633.

    Article  CAS  PubMed  Google Scholar 

  3. Buckley RH, Schiff SE, Schiff RI, Markert L, Williams LW, Roberts JL et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 1999; 340: 508–516.

    Article  CAS  PubMed  Google Scholar 

  4. Grunebaum E, Mazzolari E, Porta F, Dallera D, Atkinson A, Reid B et al. Bone marrow transplantation for severe combined immune deficiency. JAMA 2006; 295: 508–518.

    Article  CAS  PubMed  Google Scholar 

  5. Kurtzberg J, Prasad VK, Carter SL, Wagner JE, Baxter-Lowe LA, Wall D et al. Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood 2008; 112: 4318–4327.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Prasad VK, Kurtzberg J . Emerging trends in transplantation of inherited metabolic diseases. Bone Marrow Transplant 2008; 41: 99–108.

    Article  CAS  PubMed  Google Scholar 

  7. Bhattacharya A, Slatter MA, Chapman CE, Barge D, Jackson A, Flood TJ et al. Single centre experience of umbilical cord stem cell transplantation for primary immunodeficiency. Bone Marrow Transplant 2005; 36: 295–299.

    Article  CAS  PubMed  Google Scholar 

  8. Knutsen AP, Wall DA . Umbilical cord blood transplantation in severe T-cell immunodeficiency disorders: two-year experience. J Clin Immunol 2000; 20: 466–476.

    Article  CAS  PubMed  Google Scholar 

  9. Sato T, Kobayashi R, Toita N, Kaneda M, Hatano N, Iguchi A et al. Stem cell transplantation in primary immunodeficiency disease patients. Pediatr Int 2007; 49: 795–800.

    Article  CAS  PubMed  Google Scholar 

  10. Toren A, Nagler A, Amariglio N, Neumann Y, Golan H, Bilori B et al. Successful human umbilical cord blood stem cell transplantation without conditioning in severe combined immune deficiency. Bone Marrow Transplant 1999; 23: 405–408.

    Article  CAS  PubMed  Google Scholar 

  11. Weisdorf DJ, Hurd D, Carter S, Howe C, Jensen LA, Wagner J et al. Prospective grading of graft-versus-host disease after unrelated donor marrow transplantation: a grading algorithm versus blinded expert panel review. Biol Blood Marrow Transplant 2003; 9: 512–518.

    Article  PubMed  Google Scholar 

  12. Fine JPGR . A proportional hazards model for the subdistribution of a competing risk. JASA 1999; 94: 496–509.

    Article  Google Scholar 

  13. Tsuji Y, Imai K, Kajiwara M, Aoki Y, Isoda T, Tomizawa D et al. Hematopoietic stem cell transplantation for 30 patients with primary immunodeficiency diseases: 20 years experience of a single team. Bone Marrow Transplant 2006; 37: 469–477.

    Article  CAS  PubMed  Google Scholar 

  14. Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100: 1611–1618.

    CAS  PubMed  Google Scholar 

  15. Baker KS, Filipovich AH, Gross TG, Grossman WJ, Hale GA, Hayashi RJ et al. Unrelated donor hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis. Bone Marrow Transplant 2008; 42: 175–180.

    Article  CAS  PubMed  Google Scholar 

  16. Cooper N, Rao K, Goulden N, Webb D, Amrolia P, Veys P . The use of reduced-intensity stem cell transplantation in haemophagocytic lymphohistiocytosis and Langerhans cell histiocytosis. Bone Marrow Transplant 2008; 42 (Suppl 2): S47–S50.

    Article  PubMed  Google Scholar 

  17. Rao K, Amrolia PJ, Jones A, Cale CM, Naik P, King D et al. Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen. Blood 2005; 105: 879–885.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The Cord Blood Transplantation Study (COBLT) was conducted and supported by NHLBI in collaboration with the COBLT Study Investigators. This paper was prepared using a limited access dataset obtained from NHLBI and does not necessarily reflect the opinions or views of COBLT or NHLBI. This study was supported in part by Vanderbilt CTSA Grant UL1 RR024975 from NCRR/NIH.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H Frangoul.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Frangoul, H., Wang, L., Harrell, F. et al. Unrelated umbilical cord blood transplantation in children with immune deficiency: results of a multicenter study. Bone Marrow Transplant 45, 283–288 (2010). https://doi.org/10.1038/bmt.2009.137

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2009.137

Keywords

This article is cited by

Search

Quick links